The CRP gene encodes C-reactive protein, an acute-phase reactant primarily synthesized by the liver that belongs to the pentraxin family, a group of proteins characterized by a conserved cyclic pentameric structure essential for innate immunity and inflammatory responses. CRP functions as a pattern recognition molecule that binds to phosphocholine residues on the surfaces of pathogens, necrotic cells, and bacterial polysaccharides, thereby facilitating the clearance of apoptotic cells and microbes. Upon binding its ligands, CRP activates the classical complement pathway by recruiting C1q and promotes opsonization to enhance phagocytosis. Its expression is tightly regulated by pro-inflammatory cytokines, particularly interleukin-6 (IL-6), leading to a rapid increase in circulating levels within hours of infection or tissue injury, which makes CRP a widely used clinical biomarker for assessing inflammation severity, monitoring therapeutic responses, and predicting cardiovascular risk. Persistent elevation of CRP is strongly associated with chronic inflammatory conditions, including atherosclerosis and autoimmune diseases such as rheumatoid arthritis, where it contributes to vascular inflammation and foam cell formation, accelerating plaque progression. While rare severe mutations can alter baseline CRP levels, common single nucleotide polymorphisms (SNPs) are often linked to variations in steady-state concentrations. Comparative studies with other pentraxins, such as serum amyloid P (SAP), highlight shared calcium-dependent ligand binding and immunomodulatory functions, although SAP is more specifically involved in amyloid deposition regulation. Experimental evidence from gene knockout mice indicates that while CRP deficiency has minimal impact on basal physiology, it significantly impairs the host's defensive capacity against bacterial infections, underscoring its critical role in the acute inflammatory response.
Subcellular localization of CRP (and its protein):
Gene Ontology (GO) terms for CRP:
| Interacting Gene | Interaction | Source/Score |
| Name |
|---|
| Classical antibody-mediated complement activation |
| Complement cascade |
| Creation of C4 and C2 activators |
| Immune System |
| Initial triggering of complement |
| Innate Immune System |
| Disease | Score | NofPmids | NofSnps | Source |
| Inflammation | 0.269269637 | 31 | 0 | CTD_human_GAD_LHGDN_RGD |
| Rheumatoid Arthritis | 0.232003854 | 66 | 4 | BeFree_CTD_human_GAD_LHGDN_RGD |
| Cardiovascular Diseases | 0.226305284 | 140 | 7 | BeFree_CTD_human_GAD_LHGDN |
| Hypertensive disease | 0.222960395 | 37 | 4 | BeFree_CTD_human_GAD_LHGDN_RGD |
| Myocardial Ischemia | 0.209815515 | 14 | 0 | BeFree_CTD_human_GAD_RGD |
| Atherosclerosis | 0.193701127 | 94 | 0 | BeFree_CTD_human_GAD_LHGDN |
| Coronary Artery Disease | 0.167287932 | 62 | 4 | BeFree_CTD_human_GAD_LHGDN |
| Obesity | 0.150955643 | 58 | 8 | BeFree_CTD_human_GAD |
| Lupus Erythematosus, Systemic | 0.14570849 | 23 | 0 | BeFree_CTD_human_GAD_LHGDN |
| Metabolic Syndrome X | 0.13695888 | 37 | 3 | BeFree_CTD_human_GAD_LHGDN |
No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong
Qilu Normal University · Genelibs Bioinformatics Lab
750 Shunhua Rd, Jinan
2F, Bldg F, University Science Park
Tel: 0531-88819269
Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.
Business Email
E-mail: product@genelibs.com